Dose–response effects for depression and Schizophrenia management on hospital utilization in Illinois Medicaid: a multivariate regression analysis

Abstract

BackgroundThe prevalence of schizophrenia and depression in the United States is far higher among Medicaid recipients than in the general population. Individuals suffering from mental illness, including schizophrenia and depression, also have higher rates of emergency department utilization, which is costly and may not generate the positive health outcomes desired. Disease management programs strive to help individuals suffering from chronic illnesses better manage their condition(s) and seek health care in the appropriate settings. The objective of this manuscript is to estimate a dose–response impact on hospital inpatient and emergency room utilizations for any reason by Medicaid recipients with depression or schizophrenia who received disease management contacts.MethodsMultivariate regression analysis of panel data taken from administrative claims was conducted to test the hypothesis that increased contacts lower the likelihood of all-cause inpatient admissions and emergency room visits. Subjects included 6,274 members of Illinois’ non-institutionalized Medicaid-only aged, blind or disabled population diagnosed with depression or schizophrenia. The statistical measure is the odds ratio. The odds ratio association is between the monthly utilization indicators and the number of contacts (doses) a member had for each particular disease management intervention.ResultsHigher numbers of intervention contacts for Medicaid recipients diagnosed with depression or schizophrenia were associated with statistically significant reductions in all-cause inpatient admissions and emergency room utilizations.ConclusionsThere is a high correlation between depression and schizophrenia disease management contacts and lowered all-cause hospital inpatient and emergency room utilizations.

Welfare participation and depression among youth in the United States: A systematic review

“…Notably, about 1 in 4 low-income persons who qualify for Medicaid also suffers from a mental health or behavioral health disorder (Centers for Medicare and Medicaid Services, 2017). Overall, Medicaid recipients have significantly higher rates of both schizophrenia and depression than the general population (Berg, Donnelly, Warnick, Medina, & Miller, 2014). Medicaid plays an important role in providing access to mental health services for those who would otherwise be unable to afford treatment.…”

Comparing the Effects of Adjunct Aspirin and Simvastatin on Psychopathology Among Inpatients With Schizophrenia

“…Schizophrenia is associated with 3 different symptoms: positive, negative, and cognitive, with significant public health implications [5]. Positive symptoms are the most straightforward manifestations to be detected and are considered "psychotic behaviors not seen in healthy people" [6]. On the other hand, the most difficult symptoms to be identified are negative ones: such symptoms could be primarily linked with the diagnosis of this illness or be secondary to another psychotic condition, adverse effects of pharmacotherapy, or simply raised by the effects of the surrounding environment of the patient [6].…”